Home/Filings/4/0001628280-22-006408
4//SEC Filing

Bartram Richard 4

Accession 0001628280-22-006408

CIK 0001434868other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 5:09 PM ET

Size

6.2 KB

Accession

0001628280-22-006408

Insider Transaction Report

Form 4
Period: 2022-03-14
Bartram Richard
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-03-14+37,00082,751 total
Holdings
  • Stock Option (right to buy

    Exercise: $4.74Exp: 2032-03-14Common Stock (159,000 underlying)
    159,000
Footnotes (2)
  • [F1]The awards will vest quarterly over four years beginning on March 15, 2022.
  • [F2]Consists of 82,751 shares of common stock held, including 1,899 shares acquired in Esperion's Employee Stock Purchase Plan.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001723729

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:09 PM ET
Size
6.2 KB